Can a transplant drug ward off infections? small study aims to find out
NCT ID NCT07054320
First seen Oct 31, 2025 · Last updated May 16, 2026 · Updated 26 times
Summary
This pilot study is testing whether a low dose of oral rapamycin (a drug normally used after organ transplants) can help prevent infections or make them less severe. Fifteen adults will take the drug for 6 months while researchers track their blood work, symptoms, and quality of life. The goal is to see if the drug is safe and shows promise for fighting infectious diseases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTIOUS DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hoskinson Health and Wellness Clinic
Gillette, Wyoming, 82718, United States
Conditions
Explore the condition pages connected to this study.